|
Match
|
Document |
Document Title |
|
|
US20110250153 |
OLIGOMERIC BIOSURFACTANTS IN DERMATOCOSMETIC COMPOSITIONS
Oligomeric acylated biosurfactants (“OABs”) having low critical micelle concentrations of from about 1.0 ppm to about 200 ppm, preferably less than about 50 ppm, in an aqueous solution of Min...
|
|
|
US20120220669 |
FORMULATIONS FOR THE TREATMENT OF DEEP TISSUE PAIN
Disclosed herein are vesicular formulations comprising one or more phospholipids and one or more nonionic surfactants that are effective in the treatment of pain or inflammation or osteoarthritis,...
|
|
|
US20110312496 |
PESTICIDES FORMULATIONS
Concentrated microemulsions comprising: 1) 10-25 parts by weight of a pesticide with a solubility in water at 20° C. lower than 1% l by weight and having a melting point from 10° C. to 60° C.; 2)...
|
|
|
US20120201901 |
Topical Antibiotic Formulations
A biocompatible putty formulation suitable for insertion within chronic and acute wounds of humans and animals, the formulation containing a topical antibiotic, a biocompatible humectant, a...
|
|
|
US20110224723 |
CYANOACRYLATE TISSUE ADHESIVES
A tissue adhesive including cyanoacrylate and polyethylene glycol (PEG), wherein the PEG remains a polyether and wherein the tissue adhesive is bioabsorbable. A tissue adhesive including...
|
|
|
US20120308617 |
PHOSPHOLIPID-BASED INHALATION SYSTEM
The present invention includes a method for delivering medications deeper into the lungs and to the medications' pulmonary targets, which include bronchioles and alveoli. A first particularly...
|
|
|
US20110039800 |
PROLONGED RELEASE BIOADHESIVE THERAPEUTIC SYSTEMS
The present invention concerns a prolonged release bioadhesive mucosal therapeutic system containing at least one active principle, with an active principle dissolution test of more than 70% over 8...
|
|
|
US20120145590 |
Solvent Composition For Conversion Of Makeup Cosmetic
Problem: To provide a technique of simply and easily convert a powder makeup cosmetic such as powdery foundation or the like into a pickering-emulsificated liquid makeup cosmetic such as liquid...
|
|
|
US20120233728 |
LIPID LAYER FORMING COMPOSITION FOR ADMINISTRATION ONTO A SURFACE OF A LIVING ORGANISM
A lipid layer forming composition comprises a volatile silicone oil of a boiling point above 180° C., a polar lipid, optionally a C2-C4 aliphatic alcohol, optionally a pharmacologically or ...
|
|
|
US20110223257 |
RELEASABLE FUSOGENIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS
The present invention relates to releasable fusogenic lipids and nanoparticle compositions containing the same for the delivery of oligonucleotides and methods of modulating gene expression using...
|
|
|
US20120171270 |
DUAL ACTION ORGANIC FORMULATION TO CONTROL TWO STAGES OF INSECT PESTS
The present invention discloses systems and methods for controlling arthropod populations. The systems include a polymeric substrate, a semiochemical that is reactive upon an adult-stage arthropod,...
|
|
|
US20110305769 |
BRANCHED CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM
The present invention is directed to cationic lipid for the delivery of oligonucleotides and methods of modulating an expression of a targeted gene using the nanoparticle compositions. In...
|
|
|
US20110091404 |
COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE
The invention relates to the use of n-hexadecyl n-nonanoate (CAS number 72934-15-7, hereafter cetyl nonanoate) and n-octadecyl n-nonanoate (CAS number 107647-13-2, hereafter stearyl nonanoate) and...
|
|
|
US20110305770 |
RELEASABLE POLYMERIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEM
The present invention relates to polymer conjugated releasable lipids and nanoparticle compositions containing the same for the delivery of nucleic acids and methods of modulating gene expression...
|
|
|
US20110229581 |
RELEASABLE CATIONIC LIPIDS FOR NUCLEIC ACIDS DELIVERY SYSTEMS
The present invention is directed to releasable cationic lipids and nanoparticle compositions for the delivery of nucleic acids and methods of modulating an expression of a target gene using the...
|
|
|
US20130072575 |
Method and Composition for Treating Pain
Presented are methods of using topical analgesic compositions for rapid relief of muscular aches and pain where the analgesic composition has been stored at a temperature of less than 10° ...
|
|
|
US20110105433 |
LECITHIN AND LC-PUFA
The present invention relates generally to the prevention/and or stopping of the generation of off-flavours in food products. In particular is the present invention directed to the formulation of...
|
|
|
US20120101088 |
Transmembrane Penetration Enhancer
A transmembrane penetration enhancer includes a thermotropic liquid crystal suitably prepared for use in a therapeutic system to improve delivery of at least one active ingredient across a...
|
|
|
US20120183602 |
LIPID FORMULATION
The invention features a cationic lipid of formula I, an improved lipid formulation comprising a cationic lipid of formula I and corresponding methods of use. Also disclosed are targeting lipids,...
|
|
|
US20100324120 |
LIPID FORMULATION
The invention features a cationic lipid of formula I, an improved lipid formulation comprising a cationic lipid of formula I and corresponding methods of use. Also disclosed are targeting lipids,...
|
|
|
US20120058144 |
LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having...
|
|
|
US20110271973 |
SOLUTION FOR FORMING DOUBLE EYELID AND METHOD FOR FORMING DOUBLE EYELID USING SAME
[Object] To provide a solution for forming a double eyelid which enables extremely easy formation of a natural and ideal double eyelid without giving a displeased feeling or an uncomfortable...
|
|
|
US20100329982 |
PARTICLES WITH INDUCIBLE CHANGE OF SHAPE
The invention relates to particles which exhibit a stimulable shape change and allow control of their uptake in active cells. The particles can be used as carrier systems for bioactive molecules or...
|
|
|
US20130046028 |
Cosmetic Raw Material
A cosmetic raw material comprising the following components (A), (B), and (C): (A) a specific polyether-modified organopolysiloxane; (B) a chain-form silicone oil that is a liquid at 25° C., does ...
|
|
|
US20120276182 |
METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS
The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need...
|
|
|
US20110262549 |
LIPID PELLETS WITH ENHANCED TASTE-MASKING
The present invention relates to pellets obtainable by a method for preparing solid pellets by cold solvent-free extrusion. Said pellets are characterized by having spherical shape and a lipid...
|
|
|
US20080200565 |
Surfactant-only microemulsions for cleaning system design and product delivery
Surfactant systems are provided that, upon contact with an oil, can produce a Windsor Type III middle phase microemulsion at a total surfactant concentration of 1.5% to 1.0% or less based on the...
|
|
|
US20120135065 |
Amphoteric Liposomes, A Method Of Formulating An Amphoteric Liposome And A Method Of Loading An Amphoteric Liposome
An amphoteric liposome composed of a mixture of lipids, said mixture comprising a cationic amphiphile, an anionic amphiphile and optionally one or more neutral amphiphiles, at least one of said...
|
|
|
US20110171152 |
High Shine, Stick-Shaped Cosmetic Products
The present invention provides a cosmetic composition having a gloss of at least about 85 gloss units (gu), as well as sufficient shape retention properties for forming a stick-shaped cosmetic...
|
|
|
US20120004325 |
Insecticidal or acaricidal formulations with improved availability on plant surfaces
The invention relates to the use of compositions comprising at least one insecticide or acaricide, at least one nonionic and/or one ionic dispersant and an aqueous polymer dispersion for improving...
|
|
|
US20110123619 |
BUCCAL DELIVERY SYSTEM
A buccal delivery system capable of being blended in a normal dry powder process and compressed using a standard tabletting machine, said buccal delivery system comprising a matrix of: (a) an...
|
|
|
US20110319499 |
Methods for the Detection of Advanced Glycation Endproducts and Markers for Disease
The present invention provides compositions and methods for detecting carboxymethyl-lysine (CML) and circulating receptor for advanced glycation end (RAGE) products, and methods for correlating CML...
|
|
|
US20120214879 |
CHEMICAL SYSTEM WITH SELF-TIMING INDICATOR
A pH-modified luminescent composition and methods. In composition, a marker exhibiting luminescence change over a indicatory period. pH-based luminesce change may be in intensity or in wavelength....
|
|
|
US20120289614 |
FUNCTIONALIZED BIODEGRADABLE TRICLOSAN MONOMERS AND OLIGOMERS FOR CONTROLLED RELEASE
This invention relates to the discovery of functionalized triclosan monomers and oligomers that, when incorporated into a substrate of, or applied as part of a coating to, medical devices and/or...
|
|
|
US20120095114 |
FUNCTIONALIZED BIODEGRADABLE TRICLOSAN MONOMERS AND OLIGOMERS FOR CONTROLLED RELEASE
This invention relates to the discovery of functionalized triclosan monomers and oligomers that, when incorporated into a substrate of, or applied as part of a coating to, medical devices and/or...
|
|
|
US20120309836 |
METHODS AND COMPOSITIONS FOR ADMINISTRATION OF TRPV1 AGONISTS
Compositions are provided that contain a TRPV1 agonist, such as capsaicin, and a solvent system. Topical application of the composition results in rapid delivery of agonist to the dermis and...
|
|
|
US20120121695 |
ACOUSTICALLY SENSITIVE DRUG DELIVERY PARTICLES COMPRISING NON-LAMELLAR FORMING PHOSPHATIDYLETHANOLAMINE
Novel acoustically sensitive drug carrying particles comprising non-lamellar forming lipids are disclosed, as well as uses and methods thereof. The drug carrying particles accumulate in the...
|
|
|
US20110123601 |
BIOFUNCTIONALIZED PHOSPHOLIPID-CAPPED MESOPOROUS SILICA NANOSHUTTLES FOR TARGETED DRUG DELIVERY
The present invention provides a multilayer vehicle, including a mesoporous silica core and a lipid bilayer coating thereon. Hydrophobic molecules are formed between the silica core and lipid...
|
|
|
US20120328538 |
Glycerine Based Jelly Compositions
The present disclosure describes a replacement for petroleum jelly as a base for products which is suitable for most any application for which petroleum jelly can be used. The jelly is a glycerine...
|
|
|
US20120016039 |
USE OF OLIVE-OIL-DERIVED COMPOUNDS AS SURFACTANTS
The use of—olive-oil—derived compounds as surfactants is described, wherein such olive-oil-derived compounds are obtained by olive oil transesterification. Preferably, such compounds are a mix...
|
|
|
US20120027796 |
NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
The present invention provides lipids that are advantageously used in lipid particles for the in vivo delivery of therapeutic agents to cells. In particular, the invention provides lipids having...
|
|
|
US20110268653 |
Compositions and Methods Related to Acid Stable Lipid Nanospheres
The present invention relates generally to the fields of chemistry and biochemistry. More particularly, it concerns methods and compositions for the use of fatty asparagine, fatty cysteine, and...
|
|
|
US20120165415 |
EMULSION SYSTEM DERIVES FROM ENGKABANG FAT ESTERS
An isotropic or homogeneous emulsion system comprises an oil phase including fat esters of illipe fat and a solubilizer; a non-ionic surfactants; and deionized water; characterized in that the...
|
|
|
US20100062067 |
COMPOSITIONS COMPRISING MACROMOLECULAR ASSEMBLIES OF LIPID AND SURFACTANT
A composition comprising lipid and surfactant, characterised in that the lipid and surfactant are in the form of macromolecular assemblies of less than 100 nm in diameter. The surfactant can have a...
|
|
|
US20100316585 |
Use of Magnesium Stearate Dihydrate for Lubrication of Solid Industrial or Consumer Products
The invention provides lubricant compositions comprising magnesium stearate dihydrate. The lubricant compositions may be used to lubricate a variety of solid materials that are used in industrial...
|
|
|
US20090076173 |
Delivery System for a Hygienic Agent
A delivery system for a hygienic agent according to the present invention includes an agent in a viscous paste and/or semi-solid gel form, which includes a skin benefiting composition containing...
|
|
|
US20080146490 |
Glp-1 Analogue Formulations
The present invention relates to compositions forming a low viscosity mixture of: a) at least one neutral diacyl lipid, such as a diacyl glycerol; b) at least one phospholipid, such as a...
|
|
|
US20120128760 |
LIPID COMPOSITIONS
Disclosed herein are lipid compositions comprising a cationic lipid of formula (I), a neutral lipid, a sterol and a PEG or PEG-modified lipid, wherein formula (I) is (F). Also disclosed are methods...
|
|
|
US20120100077 |
MIXTURE OF AMPHIPATHIC MOLECULES AND METHOD FOR MODIFYING CELL MEMBRANES BY MEANS OF FUSION
Disclosed is a mixture of amphipathic molecules and a method for modifying cells in vivo by way of membrane fusion with these molecules.
|
|
|
US20110105449 |
DRY POWDER FORMULATIONS COMPRISING ASCORBIC ACID DERIVATES
The invention provides dry powder pharmaceutical formulations comprising an ascorbic acid derivative that demonstrate good inhalation performance and dry powder inhalers containing them.
|